Global /India /Healthcare /Drug Manufacturers - General /PGHL

Procter & Gamble Health Ltd.

PGHL

• NSE: PGHL • Delayed

5,216.90INR 1.6%

54.70 USD

As of 13 June 2026, Procter & Gamble Health Ltd. has a market cap of $892.33M USD, ranking #11368 globally and #622 in India. It ranks #1027 in the Healthcare sector, and #385 in the Drug Manufacturers - General industry.

Global Rank

11368

Country Rank

622

Sector Rank

1027

Industry Rank

385

Key Stats

Market Cap

$892.33MUSD

85.09B INR

Enterprise Value

$862.85MUSD

82.29B INR

Revenue (TTM)

$141.41MUSD

13.49B INR

EBITDA (TTM)

$41.34MUSD

3.94B INR

Net Income (TTM)

$30.78MUSD

2.93B INR

EBITDA Margin

29%

Profit Margin

22%

PE Ratio

29.0

Forward PE

27.0

PS Ratio

6.3

PB Ratio

13.7

EV/EBITDA

20.7

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Milind Thatte open_in_new

Employees

1,326

Founded

1967

Website

pghealthindia.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.6%	1%	5.7%	-4.6%	-17%	-10%	0.6%	10%	-20%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	PGHL Procter & Gamble Health Ltd ISIN: INE199A01012 Shares Out.: Shares Outstanding: 16.599M¹ Shares Float: 7.936M² TV: TradingView: NSE: PGHL SA: Stock Analysis: NSE: PGHL YF: Yahoo Finance: PGHL.NS GF: Google Finance: NSE: PGHL BA: Barron's: PGHL MS: Morningstar: XNSE: PGHL	5,216.90 INR	TV: TradingView: NSE: PGHL SA: Stock Analysis: NSE: PGHL YF: Yahoo Finance: PGHL.NS GF: Google Finance: NSE: PGHL BA: Barron's: PGHL MS: Morningstar: XNSE: PGHL
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	500126 (PGHL) Procter & Gamble Health Ltd ISIN: INE199A01012 TV: TradingView: BSE: PGHL SA: Stock Analysis: BOM: 500126 YF: Yahoo Finance: 500126.BO GF: Google Finance: BOM: 500126 BA: Barron's: 500126 MS: Morningstar: XBOM: 500126	5,126.30 INR	TV: TradingView: BSE: PGHL SA: Stock Analysis: BOM: 500126 YF: Yahoo Finance: 500126.BO GF: Google Finance: BOM: 500126 BA: Barron's: 500126 MS: Morningstar: XBOM: 500126

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Procter & Gamble Health Ltd.

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$44.75B 4.27T INR 5K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.19B 1.73T INR 2K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.01B 1.43T INR 2K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.61B 1.11T INR 1K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.77B 931.67B INR 995%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.61B 916.53B INR 977%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 85K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 61K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 40K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 36K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 32K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 31K%	20.5	Switzerland

chevron_leftBack